NCT05577637View on ClinicalTrials.gov

Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

PHASE1CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions

Vitiligo

Interventions

DRUG

0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily

0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily

Trial Locations (1)

22020

cmh Abbottabad, Abbottabad

All Listed Sponsors

lead

Combined Military Hospital Abbottabad

OTHER